Noninvasive Brain Stimulation in Adult Amblyopia
Launched by MIDWESTERN UNIVERSITY · Nov 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment for adults with amblyopia, which is often called "lazy eye." The researchers want to see if a method called non-invasive brain stimulation can help improve vision by making changes in the brain's visual area. They will look at how this treatment affects different visual skills and whether the effects last after several sessions. Participants will be divided into two groups: one group will receive the real stimulation, while the other will get a fake version that doesn’t have any active effect.
To join the study, participants need to be between 18 and 55 years old and have a formal diagnosis of amblyopia. However, people with certain medical conditions or who have specific implants like pacemakers cannot participate. If you decide to take part, you can expect to undergo testing on various aspects of your vision before and after the treatment sessions. This study aims to find out if this new approach can really help improve vision in adults with amblyopia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults between 18 and 55 years of age
- • Formal diagnosis of amblyopia in one or both eyes of any etiology
- Exclusion Criteria:
- • History of optic nerve disease, including glaucoma and optic neuritis
- • History of neurological conditions, including demyelinating disease or stroke
- • Presence of metal or electronic implants in or on the body, including pacemakers
- • Taking medications that can affect normal neurological function, including antipsychotics, antiepileptics, and opioids
About Midwestern University
Midwestern University is a distinguished academic institution dedicated to advancing healthcare education and research. With a mission to prepare healthcare professionals through innovative clinical training and a commitment to community service, the university conducts clinical trials that contribute to the development of new therapies and treatment protocols. Emphasizing collaboration and ethical practices, Midwestern University leverages its diverse healthcare programs to facilitate cutting-edge research, enhancing the quality of patient care and fostering advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Downers Grove, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported